-
61.发明公开公开(公告)号：US20240062901A1
公开(公告)日：2024-02-22
申请号：US18242386
申请日：2023-09-05
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Ulf Hedin , Ljubica Matic , Matthew Phillips
Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a lipid-lowering therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
-
62.发明授权公开(公告)号：US11887734B2
公开(公告)日：2024-01-30
申请号：US17838148
申请日：2022-06-10
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Ulf Hedin , Ljubica Matic , Matthew Phillips
Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a lipid-lowering therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
-
公开(公告)号：US20230420144A1
公开(公告)日：2023-12-28
申请号：US18240206
申请日：2023-08-30
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Ulf Hedin , Ljubica Matic , Matthew Phillips
CPC classification number: G16H50/50 , G06T7/0012 , G06T2207/30101 , G16H50/70 , G16H20/10 , G16B5/00
Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a lipid-lowering therapy for a patient with known or suspected atherosclerotic cardiovascular disease, such as atherosclerosis.
-
64.发明公开公开(公告)号：US20230386634A1
公开(公告)日：2023-11-30
申请号：US18232231
申请日：2023-08-09
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Ulf Hedin , Ljubica Matic , Matthew Phillips
Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of an anti-inflammatory therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
-
65.发明公开公开(公告)号：US20230245775A1
公开(公告)日：2023-08-03
申请号：US18113944
申请日：2023-02-24
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Ulf Hedin , Ljubica Matic , Matthew Phillips
Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a lipid-lowering therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
-
Patent Agency Ranking
公开(公告)号：US20230237759A1
公开(公告)日：2023-07-27
申请号：US18166284
申请日：2023-02-08
Applicant: ELUCID BIOIMAGING INC.
Inventor： Andrew J. BUCKLER , Kjell JOHNSON , Xiaonan MA , Keith A. MOULTON , Mark A. BUCKLER , Vladimir VALTCHINOV , David S. PAIK
IPC: G06V10/25 , G06T7/00 , G06T7/11 , G06N20/00 , G06N3/08 , G06T5/00 , G06T3/00 , G06V20/69 , G06F18/24 , G06F18/211 , G06F18/214 , G06V10/764
CPC classification number: G06V10/25 , G06T7/0012 , G06T7/11 , G06N20/00 , G06N3/08 , G06T5/003 , G06T3/00 , G06V20/69 , G06F18/24 , G06F18/211 , G06F18/2148 , G06V10/764 , G06T2207/10132 , G06T2207/10081 , G06T2207/10088 , G06T2207/10101 , G06T2207/10104 , G06T2207/10108 , G06T2207/10048 , G06T2207/20081 , G06T2207/30096 , G06T2207/30104
Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
-
公开(公告)号：US11607179B2
公开(公告)日：2023-03-21
申请号：US17328417
申请日：2021-05-24
Applicant: ELUCID BIOIMAGING INC.
Inventor： Andrew J. Buckler , Kjell Johnson , Xiaonan Ma , Keith A. Moulton , Mark A. Buckler , Vladimir Valtchinov , David S. Paik
IPC: G06T7/00 , A61B5/00 , G06T5/00 , G06T5/20 , G06T11/00 , G06T11/60 , A61B6/00 , G16H30/40 , G06N3/08 , A61B5/103 , G16H50/20 , G16H50/50 , G16H10/60 , A61B5/02 , A61B5/055 , A61B8/08 , A61B5/107 , A61B6/03 , A61B5/145
Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
-
68.发明申请公开(公告)号：US20230005582A1
公开(公告)日：2023-01-05
申请号：US17838146
申请日：2022-06-10
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Ulf Hedin , Ljubica Matic , Matthew Phillips
Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of an anti-inflammatory therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
-
69.发明申请公开(公告)号：US20220409160A1
公开(公告)日：2022-12-29
申请号：US17838140
申请日：2022-06-10
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Ulf Hedin , Ljubica Matic , Matthew Phillips
Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a combination of any two or more therapies selected from a lipid-lowering therapy, an anti-inflammatory therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
-
70.发明申请公开(公告)号：US20220406459A1
公开(公告)日：2022-12-22
申请号：US17838148
申请日：2022-06-10
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Ulf Hedin , Ljubica Matic , Matthew Phillips
Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a lipid-lowering therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
-
-
-
-
-
-
-
-
-
Search Results
98
records
(took 0.032 seconds)
